PICKERING, ON, March 25, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQB: MTLNF) ("MTL" or the "Company") is pleased to announce that its common shares will commence trading on the OTCQB marketplace under the symbol "MTLNF" as of the opening of markets today. The Company's shares will continue to trade on the Canadian Securities Exchange under the symbol "MTLC".
MTL Cannabis Corp. logo (CNW Group/MTL Cannabis Corp.)
The listing on the OTCQB is a step in enhancing the Company's visibility and accessibility for U.S. investors. This milestone is expected to improve liquidity and expand MTL's reach into the U.S. investment market.
"The OTCQB listing marks a significant milestone for MTL Cannabis Corp. as we expand our presence and accessibility in the US market," said Michael Perron, CEO of MTL Cannabis Corp. "This step underscores our commitment to growing shareholder value by reaching a broader investor base, increasing liquidity, and positioning MTL Cannabis Corp. as a key player in the global cannabis industry. The US market's depth and engagement present opportunities for the Company's continued growth and development."
The OTCQB Venture Market provides an established platform for early-stage and growth companies to enhance their visibility in the U.S. market. Companies listed on OTCQB must meet rigorous reporting standards, undergo annual verification, and comply with management certification requirements, providing investors with a trusted market for trading. Real-time quotes and market information on MTL Cannabis Corp. can be found at www.otcmarkets.com.
About MTL Cannabis Corp.
MTL Cannabis Corp. is the parent company of Montréal Medical Cannabis Inc. ("MTL Cannabis"), a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.
As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis.
It is MTL's goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services.
This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities and repay its outstanding indebtedness; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; the ability to execute strategic plans; continued integration of business unit, expansion activities at all our operating locations; and the leveraging of cash flow from operations to accelerate growth and further improve the Company's balance sheet. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
